Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy

Annals of Surgery

Volumn 243, Issue 2, 2006, Pages 257-264

  Chagpar, Anees B ^a,b   Middleton, Lavinia P ^a   Sahin, Aysegul A ^a   Dempsey, Peter ^a   Buzdar, Aman U ^a   Mirza, Attiqa N ^a   Ames, Fredrick C ^a   Babiera, Gildy V ^a   Feig, Barry W ^a   Hunt, Kelly K ^a   Kuerer, Henry M ^a   Meric Bernstam, Funda ^a   Ross, Merrich I ^a   Singletary, S Eva ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN;

ACCURACY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PACLITAXEL; PHYSICAL EXAMINATION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY, MAMMARY;

EID: 31844444246     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000197714.14318.6f     Document Type: Article

References (27)

1. Shannon C, Smith I. Is there still a role for neoadjuvant therapy in breast cancer? Crit Rev Oncol Hematol. 2003;45:77-90.
2. Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;16:2672-2685.
3. Kuerer HM, Singletary SE, Buzdar AU, et al. Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg. 2001;182:601-608.
4. Vlastos G, Mirza NQ, Lenert JT, et al. The feasibility of minimally invasive surgery for stage IIa, IIb, and IIIa breast carcinoma patients after tumor downstaging with induction chemotherapy. Cancer. 2000; 88:1417-1424.
5. Forouhi P, Walsh JS, Anderson TJ, et al. Ultrasonography as a method of measuring breast tumor size and monitoring response to primary systemic treatment. Br J Surg. 1994;81:223-225.
6. Gawne-Cain ML, Smith E, Darby M, et al. The use of ultrasound for monitoring breast tumor response to pro-adjuvant therapy. Clin Radiol. 1995;50:681-686.
7. Herrada J, Iyer RB, Atkinson N, et al. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res. 1997;3:1565-1569.
8. Akashi-Tanaka S, Fukutomi T, Watanabe T, et al. Accuracy of contrast-enhanced computed tomography in the prediction of residual breast cancer after neoadjuvant chemotherapy. Int J Cancer. 2001; 96:66-73.
9. Fiorentino C, Berruti A, Bottini A, et al. Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. Breast Cancer Res Treat. 2001;69:143-151.
10. Fornage BD, Toubas O, Morel M. Clinical, mammographic and sonographic determination of preoperative breast cancer size. Cancer. 1987; 60:765-771.
11. Madjar H, Ladner HA, Sauerbrei W, et al. Preoperative staging of breast cancer by palpation, mammography and high-resolution ultrasound. Ultrasound Obstet Gynecol. 1993;3:185-190.
12. Davis PL, Staiger MJ, Harris KB, et al. Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography. Breast Cancer Res Treat. 1996;37:1-9.
13. Yang WT, Lam WWM, Cheung H, et al. Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer. J Ultrasound Med. 1997;16:791-797.
14. Tressara F, Feu J, Grases PJ, et al. Assessment of breast cancer size: sonographic and pathological correlation. J Clin Ultrasound. 1999;27: 485-491.
15. Hieken TJ, Harrison J, Herreros J, et al. Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg. 2001;182:351-354.
16. Bosch AM, Kessels AG, Beets GL, et al. Preoperative estimation of the pathological breast tumor size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumors. Eur J Radiol. 2003;48:285-292.
17. Golshan M, Fung BB, Wiley E, et al. Prediction of breast cancer size by ultrasound, mammography and core biopsy size. Breast. 2004;13:265-271.
18. Pritt B, Ashikaga T, Oppenheimer RG, et al. Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements. Mod Pathol. 2004;17:905-910.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
20. Franzblau A. A Primer of Statistics for Non-Statisticians. New York: Harcourt, Brace & World, 1958.
21. Nakamura T, Fukutomi T, Tsuda H, et al. Changes in finds of mammography, ultrasonography and contrast-induced computed tomography of three histological complete responders with primary breast cancer before and after neoadjuvant chemotherapy: case reports. Jpn J Clin Oncol. 2000;30:453-457.
22. Singletary SE. Radiofrequency ablation of breast cancer. Am Surg. 2003;69:37-40.
23. Rosen EL, Blackwell KL, Baker JA, et al. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol. 2003;181:1275-1282.
24. Partridge SC, Gibbs JE, Lu Y, et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol. 2002;179:1193-1199.
25. Londero V, Bazzocchi M, Del Frate C, et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol. 2004;14:1371-1379.
26. Denis F, Desbiez-Bourcier AV, Chapiron C, et al. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol. 2004;30:1069-1076.
27. Harry TF, Steinert HC, Goerres GW, et al. Improvement of diagnostic accuracy of PET imaging using a high performance in-line PET-CT system: preliminary results. Radiology. 2002;225:575-581.